We will have limited operations from 15:00 Tuesday 24 December 2024 (AEDT) until Thursday 2 January 2025. Find out how to contact us during the holiday period.
Role of the ACCM
The Advisory Committee on Complementary Medicines (ACCM) provides expert advice at the request of the Minister or Secretary for Health, on the safety, efficacy and manufacturing quality of a complementary medicine in the Australian Register of Therapeutic Goods.
ACCM was formed in January 2010 under Regulation 39 of the Therapeutic Goods Regulations 1990 and the members are appointed by the Minister for Health.
ACCM supersedes the Complementary Medicines Evaluation Committee (CMEC) and has an increased focus on the advisory role within the regulatory framework of complementary medicines.
Membership comprises of professionals with specific scientific, medical, clinical expertise as well as appropriate consumer health issues relating to complementary medicines.
Membership
The current membership of the committee can be found on our ACCM members page.
2024 ACCM proposed meeting dates
Meeting no. | Meeting dates |
|---|---|
ACCM 34 | 14 March 2024 |
ACCM 35 | 11 July 2024 |
ACCM 36 | 14 November 2024 |
Contact details for the ACCM
| ACCM enquiries | Committee support enquiries | |
|---|---|---|
| nonprescriptionmedicines@health.gov.au | Committees@health.gov.au | |
| Postal Address | Advisory Committee on Complementary Medicines Therapeutic Goods Administration PO Box 100 WODEN ACT 2606 Attn: Complementary and OTC Medicines Branch, MDP 122 | Committee Support Unit Therapeutic Goods Administration PO Box 100 WODEN ACT 2606 Attn: Collaboration Services Section, MDP 122 |